	Operationalizing Alzheimer's disease trials in the era of targeted therapies. Alzheimers Dement Pillai JA, Alladi S, Appleby BS, Brosch JR, Frederiksen KS, Galasko D, Lopez OL, Leverenz JB, Saykin AJ, Schott JM, Seshadri S, Tousi B, Wolk DA. PMID: 42750195 [PubMed - indexed for MEDLINE]
	Quercetin-Based Nanotherapeutics for Targeted Drug Delivery in Alzheimer's Disease: Comparative Insights into Molecular Mechanisms, Blood-Brain Barrier Targeting and Therapeutic Perspectives. Mol Neurobiol Begum MY, Rajkumar M, Govindaraj P, Velmani S, Rajkumar P, Sudha PN, Alhamod M, Alotaibi H. PMID: 42749965 [PubMed - indexed for MEDLINE]
	Neuropsychiatric symptoms as predictors of progression to Alzheimer's disease in mild cognitive impairment: A comparative meta-analysis of apathy, depression, and anxiety. Int Psychogeriatr Sun Y, Cao Y, Ma J, Li W, Li H, Tan Z. PMID: 42749536 [PubMed - as supplied by publisher]
	Genetic susceptibility of Alzheimer's disease associated with APOE polymorphism: systematic review and bibliometric study. J Genet Eng Biotechnol Amukti DP, Kusumawardani N, Pratami RI, Purwanto BD, Rukhama RA, Akbar I, Sarwadhamana RJ, Aditya RA, Yuliani S. PMID: 42749454 [PubMed]
	Alzheimer's disease burden in China (ABC) study: protocol for a nationwide multicentre cross-sectional and prospective cohort study. BMJ Open Wang Y, Qin Q, Yang K, Yu M, Yao Y, Gong C, Guo J, Yang L, Tang Y. PMID: 42749375 [PubMed - indexed for MEDLINE]
	Inflection points and transitions in Alzheimer's disease. Nature De Strooper B, Karran E. PMID: 42749285 [PubMed - as supplied by publisher]
	From systems to cells: metabolic mechanisms underlying risk divergence in Alzheimer's disease and amyotrophic lateral sclerosis. Neurosci Biobehav Rev Knezovic A, Krsnik A, Homolak J, Perhoc AB, Deskin A, Virag D, Salkovic-Petrisic M, Barilar JO. PMID: 42749235 [PubMed - as supplied by publisher]
	Unlocking the Potential of Isatin Scaffolds in Acetylcholinesterase Inhibition. Arch Pharm (Weinheim) Tharwat T, El-Nassan HB, Adly ME, Kamel MM. PMID: 42748401 [PubMed - indexed for MEDLINE]
	Emerging therapeutic targets beyond amyloid and tau in Alzheimer's Disease: Implications for lifestyle, metabolism and preventive medicine. Wiad Lek Izhytska N, Sobczyk KA, Ogrodnik KW, Mazurkiewicz M, Malentowicz D, Szafraniec NJ, Bro, Sa, Pastuszka M. PMID: 42748320 [PubMed - indexed for MEDLINE]
	Alzheimer's Co-Pathology Burden on Basal Forebrain Atrophy and Cognitive Impairment in Dementia with Lewy Bodies: A Cross-Sectional Pilot Study. Ann Neurol Urso D, Giannelli T, Tafuri B, Giannoni-Luza S, Gnoni V, Giugno A, Vilella D, Zecca C, De Blasi R, Nigro S, Aarsland D, Logroscino G. PMID: 42747246 [PubMed - as supplied by publisher]
	Advances in N- and S-Heterocycles as c-Jun-N-Terminal Kinase 3 Inhibitors for Alzheimer's Disease Treatment. Drug Dev Res Yadav P, Mishra D, Singh R. PMID: 42747078 [PubMed - indexed for MEDLINE]
	Validation of plasma core biomarkers of Alzheimer's disease: A multicenter study in usual practice conditions. J Alzheimers Dis Sánchez-Soblechero A, Villarejo A, Carreras MT, Berbel Á, Puertas C, Fernández-Bullido Y, Vieira A, Gundín I, Blanco-Palmero V, González-Sánchez M, Llamas S, Lapeña T, de Luis P, Lucio B, Ibáñez MD, Heredia P, Grandas F, Olazarán J. PMID: 42746979 [PubMed - as supplied by publisher]
	Recognition memory as a neuropsychological marker of progression in early-stage Alzheimer's disease: a 24-month prospective cohort study. J Clin Exp Neuropsychol Russo MJ, Bueri J, Alba-Ferrara L, Sevlever G, Allegri RF. PMID: 42746710 [PubMed - as supplied by publisher]
	Designing intranasal formulations for Alzheimer's disease: A material-based perspective. Tzu Chi Med J Chen YS, Huang HY. PMID: 42746628 [PubMed]
	Clinical Practice Outcomes With Lecanemab for Alzheimer Disease. Neurol Open Access Liu AJ, Moghadam AA, Alam MS, Lutz MW, Navarra A, Luo S, Wang LA, Petrella JR, Whitson H, O'Brien RJ, Johnson KG, Parker D, Beam C, Sanfilippo M, Al-Sahlani H, Cobb S, Liu MY, Doraiswamy PM. PMID: 42746606 [PubMed]
	Investigating oral blarcamesine for treatment of early Alzheimer's disease. Expert Opin Pharmacother Chandrasekaran A, Paget-Blanc A, Decourt B, Sabbagh MN. PMID: 42745524 [PubMed - as supplied by publisher]
	Enhancing Alzheimer's disease diagnosis in primary care through targeted screening of people at risk of developing dementia - study design and feasibility assessment of the PREDEM primary care study. Alzheimers Res Ther Aye S, Åhrberg S, Carlsson AC, Hasselström J, Alshamani I, Wallen S, van den Hurk W, Lund L, Jejcic A, Broome ST, Duran Sidera A, Tjernberg L, Jönsson L, Schedin-Weiss S. PMID: 42745326 [PubMed - indexed for MEDLINE]
	Alternative splicing in Alzheimer's disease: event-level evidence, risk-locus biology, and RNA-based therapeutic perspectives. Gene Li J, Yue D, Xie W, Xiong Z, Wang X. PMID: 42744164 [PubMed - as supplied by publisher]
	Autopsy findings in Alzheimer's disease clinical trial participants demonstrate a high frequency of off-target coexisting pathologic features. J Prev Alzheimers Dis Coskun EP, Barber J, Bojarski L, McLouth CJ, Abner EL, Van Eldik LJ, Nelson PT, Jicha GA. PMID: 42743907 [PubMed - as supplied by publisher]
	Pharmacological modulation of cGAS-STING-NLRP3 signaling by nano-immunomodulators in Alzheimer and Parkinson disease. Inflammopharmacology Abdel-Rasol MA. PMID: 42742907 [PubMed - as supplied by publisher]

Articles 1 - 20 / 72279

Page 1 of 3614



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy